United Therapeutics Corp logo

United Therapeutics Corp

4
3
NAS:UTHR (USA)   Ordinary Shares
$ 312.43 +3.445 (+1.11%) 10:37 AM EST
14.77
P/B:
2.59
Market Cap:
$ 13.86B
Enterprise V:
$ 11.60B
Volume:
123.64K
Avg Vol (2M):
569.18K
Trade In:
Volume:
123.64K
Avg Vol (2M):
569.18K

Business Description

United Therapeutics Corp logo
United Therapeutics Corp
NAICS : 325412 SIC : 2834
ISIN : US91307C1027

Share Class Description:

UTHR: Ordinary Shares
Description
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

Financials (Next Earnings Date:2024-08-02 Est.)

UTHR's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:UTHR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

United Therapeutics Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,498.3
EPS (TTM) ($) 21.15
Beta 0.74
Volatility % 25.18
14-Day RSI 84.81
14-Day ATR ($) 6.375186
20-Day SMA ($) 281.6215
12-1 Month Momentum % 22.95
52-Week Range ($) 208.6249 - 316.225
Shares Outstanding (Mil) 44.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

United Therapeutics Corp Filings

Filing Date Document Date Form
No Filing Data

United Therapeutics Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

United Therapeutics Corp Frequently Asked Questions

What is United Therapeutics Corp(UTHR)'s stock price today?
The current price of UTHR is $312.43. The 52 week high of UTHR is $316.23 and 52 week low is $208.62.
When is next earnings date of United Therapeutics Corp(UTHR)?
The next earnings date of United Therapeutics Corp(UTHR) is 2024-08-02 Est..
Does United Therapeutics Corp(UTHR) pay dividends? If so, how much?
United Therapeutics Corp(UTHR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1